Zenas BioPharma, Inc.·4

Dec 18, 4:30 PM ET

Oliveira Orlando 4

4 · Zenas BioPharma, Inc. · Filed Dec 18, 2024

Insider Transaction Report

Form 4
Period: 2024-12-16
Oliveira Orlando
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-12-16+7,7757,775 total
    Exercise: $8.77Exp: 2034-12-15Common Stock (7,775 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the underlying shares of common stock on July 1, 2025, the first anniversary of the vesting commencement date, and as to the remaining shares, in equal month installments over 36 months thereafter, subject to continued service.

Documents

1 file
  • 4
    tm2431489-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT